Skip to main content
Search

Pharmacotherapy for obesity: why it is needed

Part 1 of 2
Published on January 30, 2025   28 min

A selection of talks on Genetics & Epigenetics

Please wait while the transcript is being prepared...
0:00
I'm Joe Proietto. I am a Professor Emeritus at the University of Melbourne. I will be talking about "Pharmacotherapy for Obesity". There are two parts to this talk. Two lectures. Part 1 shows you why it's necessary to have pharmacotherapy for the rest of the life of the patient and Part 2 will talk about the agents that we have at the moment.
0:34
Before I start, I'd like to declare possible conflicts of interest. I've given lectures on the management of obesity for Novo Nordisk who markets Saxenda and Wegovy around the world, and for iNova here in Australia who are marketers of Duromine and Contrave.
1:01
There are many factors that can influence body weight. A lot of these are said to be able to lead to obesity and these include the built environment. In other words, the lifestyle we have now in modern times. Medical conditions such as, for example, Cushing's syndrome or hypothyroidism. There's quite a bit of literature about the microbes that live in our large bowel affecting weight. There's evidence for some viruses influencing weight. There are medications that can change weight such as steroids and antipsychotics, sleep deprivation, stress. Menopause is known to cause some weight gain and some environmental toxins.

Quiz available with full talk access. Request Free Trial or Login.

Show
Hide

Pharmacotherapy for obesity: why it is needed

Embed in course/own notes